Sunday, January 29, 2023

FDA denies CBD petitions, seeks ‘new regulatory pathway’

FDA cites concerns about the risks CBD poses to consumers.

Having difficulty viewing this message? View it in a browser.






Webinars - Active

No comments:

Post a Comment